TABLE 1.
Characteristics of the Study Population
| Recipient characteristics | |
| Transplants, total | 118 |
| Mean age at transplant | 53.1±8.3 |
| n (%) male | 83 (70) |
| n (%) white | 87 (74) |
| Indications for transplant, n (%) | |
| NAFLD | 21 (18) |
| Non-NAFLD | 97 (82) |
| MELD at transplant | 23.6±6.2 |
| n with diabetes (%) | 33 (28) |
| n with hypertension (%) | 34 (29) |
| n with hyperlipidemia (%) | 15 (13) |
| n with coronary artery disease (%) | 5 (4) |
| n with hepatocellular carcinoma (%) | 31 (26) |
| Mean serum sodium | 136±5.3 |
| Mean creatinine | 1.47±1.0 |
| Mean body mass index | 28.8±4.6 |
| Donor characteristics | |
| Male donors, n (%) | 43 (39) |
| Donor age | 36.2±15.3 |
| Donor type, n (%) | |
| Deceased donor | 107 (91) |
| DCD | 10 (9) |
| Donor cause of death, n (%) | |
| Anoxia | 9 (9) |
| CVA | 41 (38) |
| Trauma | 56 (52) |
| Donor Risk Index | 1.333±0.309 |
| Operative characteristics | |
| Warm ischemia time, min | 40.5±11.2 |
| Cold ischemia time, min | 420±117 |
| Retransplants required, n (%) | 13 (11) |
| Survival | |
| Overall graft survival (%) | |
| 30 d | 92.4 |
| 1 y | 82.1 |
| 3 y | 74.3 |
| Overall patient survival (%) | |
| 30 d | 94.9 |
| 1 y | 87.1 |
| 3 y | 82.3 |
NAFLD indicates nonalcoholic fatty liver disease.